Dr. Westgard takes the theory and tools of quality planning and applies it to immunoassays. This was part of his presentation to the joint meeting of UK National External Quality Assessment Schemes (UK NEQAS) for Endocrinology and the European Ligand Assay Society (ELAS) in Edinburgh, Scotland, a paper that he delivered "virtually" to the conference.